Skip to contentT
Tenon Medical, Inc.
T
TNONWTenon Medical, Inc. Q2 2026 · 10-Q
Revenue$1.28M$1.28M+126.8% vs Q2 2025 Net Income-$4.05M-$4.05MN/M vs Q2 2025 EPS Diluted-$12.35-$12.35N/M vs Q2 2025 Gross Profit$814,000+232.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenon Medical, Inc. · CIK 1560293 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,758,000N/M Free Cash Flowderived-$2,930,000— Margins · derivedGross margin63.6%+20.2 pt vs Q2 2025
Operating margin-262.2%+244.3 pt vs Q2 2025
Net margin-316.7%+174.3 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end